PHE.GOV KEYWORD DENSITY CHECKER

Total words: 2787 | 2-word phrases: 727 | 3-word phrases: 802 | 4-word phrases: 830

PAGE INFO

Title Try to keep the title under 60 characters (0 characters)
Description Try to keep the meta description between 50 - 160 characters (0 characters)
Keywords Meta keywords are not recommended anymore (0 characters)
H1 No H1 tag on the page (0 characters)

ONE WORD PHRASES 428 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1and337.71%
2for245.61%
3aspr225.14%
4of194.44%
5covid19173.97%
6in153.50%
7more122.80%
8medical122.80%
9emergency122.80%
10on122.80%

TWO WORD PHRASES 727 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1learn more91.24%
22021 fda81.10%
3of covid1970.96%
4for treatment50.69%
5monoclonal antibodies50.69%
6antibodies for50.69%
7public health50.69%
8health and50.69%
9prevention of50.69%
10fda authorizes50.69%
11in certain40.55%
12treatment of40.55%
13us on40.55%
14emergency medical40.55%
15medical countermeasure40.55%
16office of40.55%
17oral antiviral40.55%
18assistant secretary40.55%
19covid19 in40.55%
20certain individuals30.41%

THREE WORD PHRASES 802 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1monoclonal antibodies for50.62%
22021 fda authorizes40.50%
3treatment of covid1940.50%
4antibodies for preexposure30.37%
5oral antiviral for30.37%
6for treatment of30.37%
7assistant secretary for30.37%
8strategic national stockpile30.37%
9in certain individuals30.37%
10covid19 in certain30.37%
11of covid19 in30.37%
12prevention of covid1930.37%
13longacting monoclonal antibodies30.37%
14assistance program for20.25%
15after recent tornadoes20.25%
16medicine after recent20.25%
17needing medicine after20.25%
18uninsured kentucky residents20.25%
19december 23 202120.25%
20medical reserve corps20.25%
21prescription assistance program20.25%
22hhs activates emergency20.25%
232021 hhs activates20.25%
24news december 2820.25%
25emergency medical countermeasures20.25%
26medical countermeasures enterprise20.25%
27aspr 2020 year20.25%
28certain adults december20.25%
29younger pediatric patients20.25%
3003 2021 fda20.25%

FOUR WORD PHRASES 830 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1monoclonal antibodies for preexposure30.36%
2longacting monoclonal antibodies for30.36%
3for treatment of covid1930.36%
4needing medicine after recent20.24%
5oral antiviral for treatment20.24%
6additional oral antiviral for20.24%
7authorizes additional oral antiviral20.24%
8december 23 2021 fda20.24%
9medicine after recent tornadoes20.24%
102021 hhs activates emergency20.24%
11prescription assistance program for20.24%
12december 08 2021 fda20.24%
13social services emergency fund20.24%
14covid19 in certain individuals20.24%
15of covid19 in certain20.24%
16emergency medical countermeasures enterprise20.24%
17antiviral for treatment of20.24%
18december 03 2021 fda20.24%
19for preexposure prevention of20.24%
20monoclonal antibodies for treatment20.24%
21certain individuals december 0320.24%
22individuals december 03 202120.24%
23covid19 december 08 202120.24%
24of covid19 december 0820.24%
25treatment of covid19 december20.24%
26two monoclonal antibodies for20.24%
27antibodies for treatment and20.24%
28covid19 monoclonal antibody therapeutics20.24%
2922 2021 fda authorizes20.24%
30december 22 2021 fda20.24%
31adults december 22 202120.24%
32certain adults december 2220.24%
33covid19 to younger pediatric20.24%
34to younger pediatric patients20.24%
35treatment of covid19 in20.24%
36in certain individuals december20.24%
37antibodies for preexposure prevention20.24%
38department of health and20.24%
39us department of health20.24%
40new longacting monoclonal antibodies20.24%

EXTERNAL LINKS

# URL Whois Check
1http://www.hhs.gov/ Whoishhs.gov
2 https://medicalcountermeasures.gov/barda/core-services/ciadm.aspx Whois.
3 https://mrc.hhs.gov/HomePage Whois.
4 https://asprtracie.hhs.gov/ Whois.
5 https://empowermap.hhs.gov/ Whois.
6 http://geohealth.hhs.gov/arcgis/home/ Whois.
7 https://nowtrending.hhs.gov/ Whois.
8 http://chemm.nlm.nih.gov/index.html Whois.
9 http://www.remm.nlm.gov/index.html Whois.
10 http://wiser.nlm.nih.gov/ Whois.
11 http://emergency.cdc.gov/disasters/psa/ Whois.
12 https://www.hhs.gov/sites/default/files/fy-2022-phssef-cj.pdf Whois.
13 https://medicalcountermeasures.gov/barda/core-services.aspx Whois.
14 https://drive.hhs.gov/partner.html?id=applyNow Whois.
15 https://carb-x.org/ Whois.
16 https://www.medicalcountermeasures.gov/barda/barda-baa Whois.
17 https://beta.sam.gov/ Whois.
18 https://www.grants.gov/web/grants/search-grants.html?agencyCode=HHS-OS-ASPR Whois.
19 https://drive.hhs.gov/partner.html?id=applyNow Whois.
20 https://www.usphs.gov/apply/apply.aspx Whois.
21 https://www.hhs.gov/about/agencies/orgchart/aspr/index.html Whois.
22 https://cloud.connect.hhs.gov/PHE Whois.
23 https://twitter.com/asprgov Whois.
24 https://www.facebook.com/asprgov Whois.
25 https://www.flickr.com/photos/asprgov Whois.
26 https://www.youtube.com/c/ASPRgov Whois.
27 https://www.linkedin.com/showcase/hhs-aspr Whois.
28 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-long-acting-monoclonal-antibodies-pre-exposure Whois.
29 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-oral-antiviral-treatment-covid-19-certain Whoisfda.gov
30 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19 Whoisfda.gov
31 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-long-acting-monoclonal-antibodies-pre-exposure Whoisfda.gov
32 https://www.fda.gov/news-events/press-announcements/fda-expands-authorization-two-monoclonal-antibodies-treatment-and-post-exposure-prevention-covid-19 Whoisfda.gov
33 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-additional-oral-antiviral-treatment-covid-19-certain Whoisfda.gov
34 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19 Whoisfda.gov
35 https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-new-long-acting-monoclonal-antibodies-pre-exposure Whoisfda.gov
36 https://www.fda.gov/news-events/press-announcements/fda-expands-authorization-two-monoclonal-antibodies-treatment-and-post-exposure-prevention-covid-19 Whoisfda.gov
37 https://medicalcountermeasures.gov/app/barda/coronavirus/COVID19.aspx Whois.
38 https://medicalcountermeasures.gov/barda/barda-covid-19-response/ Whois.
39 https://twitter.com/asprgov Whois.
40 https://www.facebook.com/asprgov Whois.
41 https://www.instagram.com/asprgov/ Whois.
42 http://www.hhs.gov/plugins.html Whoishhs.gov
43 http://www.hhs.gov/open/plain-writing/index.html Whoishhs.gov
44 http://www.hhs.gov/ Whoishhs.gov
45 http://www.usa.gov/ Whoisusa.gov
46 http://www.usa.gov/gobiernousa/ Whoisusa.gov
47 https://www.healthcare.gov/ Whoishealthcare.gov
48 https://www.healthcare.gov/language-resource Whoishealthcare.gov